The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria

Journal of Bioenergetics and Biomembranes
Magnus J HanssonEskil Elmér

Abstract

Cyclosporin A (CsA) is highly neuroprotective in several animal models of acute neurological damage and neurodegenerative disease with inhibition of the mitochondrial permeability transition (mPT) having emerged as a possible mechanism for the observed neuroprotection. In the present study, we have evaluated two new nonimmunosuppressive cyclosporin analogs NIM811 (Novartis) and UNIL025 (Debiopharm) for their ability to inhibit mPT in rat brain-derived mitochondria. Both NIM811 and UNIL025 were found to be powerful inhibitors of calcium-induced mitochondrial swelling under energized and deenergized conditions, and the maximal effects were identical to those of native CsA. The potencies of mPT inhibition by NIM811 and UNIL025 were stronger, with almost one order of magnitude higher potency for UNIL025 compared to CsA, correlating to their respective inhibitory action of cyclophilin activity. These compounds will be instrumental in the evaluation of mPT as a central target for neuroprotection in vivo.

Citations

Nov 3, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Botros B Kostandy
Apr 29, 2010·Current Neurology and Neuroscience Reports·James Collins, Carsten G Bönnemann
Mar 2, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Melanie L McEwenJoe E Springer
Mar 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Luciano MerliniPaolo Bernardi
Jul 30, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Amanda LoGuidiceUrs A Boelsterli
Oct 16, 2012·Circulation Research·Andrew M WaltersPaul S Brookes
Sep 29, 2011·Skeletal Muscle·Valérie AllamandGisèle Bonne
Apr 26, 2014·Future Cardiology·Rachel K DongworthDerek J Hausenloy
Apr 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Michael ForteDennis Bourdette
Feb 25, 2009·Expert Opinion on Investigational Drugs·Raf CrabbéLaura Novaroli
Aug 24, 2007·Expert Opinion on Investigational Drugs·Robert FlisiakRaf Crabbé
Nov 28, 2012·Clinics in Liver Disease·Fernando E MembrenoEric J Lawitz
May 25, 2011·Pharmacology & Therapeutics·Alexander G RabchevskyJoe E Springer
Jul 20, 2010·Neuromuscular Disorders : NMD·Erin R WissingJeffery D Molkentin
Mar 10, 2010·Neuromuscular Disorders : NMD·Valérie AllamandUNKNOWN Consortium for Collagen VI-Related Myopathies
Feb 24, 2016·Biochimica Et Biophysica Acta·Lucia BiasuttoMario Zoratti
Oct 27, 2011·Oxidative Medicine and Cellular Longevity·Luciano MerliniPaolo Bernardi
May 3, 2006·The FEBS Journal·Paolo BernardiMichael A Forte
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kazuaki InoueMichinori Kohara
Dec 17, 2008·Annals of the New York Academy of Sciences·Paolo Bernardi, Paolo Bonaldo
Dec 17, 2008·Annals of the New York Academy of Sciences·Gary FiskumRobert E Rosenthal
Apr 20, 2012·Cell Calcium·Paolo Bernardi, Sophia von Stockum
Nov 15, 2008·Biochimica Et Biophysica Acta·Karin NowikovskyPaolo Bernardi
Apr 15, 2008·Biochimica Et Biophysica Acta·Anna W C Leung, Andrew P Halestrap
Apr 24, 2012·Trends in Pharmacological Sciences·Robin A J SmithMichael P Murphy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.